Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | FIST | Malaria Patent Landscape 2009

Malaria Patent Landscape 2009

IP Overview presents a patent landscape analysis of the Malaria field.

Since the discovery of the parasite responsible for Malaria in 1880, this disease has been the subject of intensive research and development within the academic and industrial sectors with a first patent filed as early as 1907 describing a quinine based treatment. Despite the small market (~1 billion $) generated by the drugs currently commercialized, more than 3000 patents describing new ways to control malaria were filed since 1980 with a growing interest over the last decade.

Next to a very dynamic institutional research, some industrials are marking out their position expecting increased reputation, but also with the hope of public and private funding and growing solvability of currently infected countries. New collab orations are f orming and companies emerge on very specific segments. With upcoming resistances, current challenges in controlling malaria consist in developing early rapid diagnostic tests, efficient and affordable preventive and curative drugs and vaccines but also in developing efficient insecticides and repellents. The R&D and patent strategy in this sector bring forth the interest of these three challenges.

In the current race for controlling malaria, this IP Overview provides you a comprehensive panorama of the intellectual property landscape and helps you:

- Position your company’s R&D and IP Portfolio

- Identify key invent ors and key players involved in specific thematic

- Understand the collab oration netw orks and theirs dynamics

- Uncover trends and emerging segments

2009, PDF

Table of Contents
Sample Pages
Price: $1,825.00 / €1,219.83

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions